MATTHEW J PFEFFER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW J PFEFFER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW J PFEFFER. MATTHEW J PFEFFER is a V.P. & Chief Financial Officer in CELL GENESYS INC ($CEGE) and a Director in SECOND SIGHT MEDICAL PRODUCTS INC ($EYES) and a CEO, CFO, Director in MANNKIND CORP ($MNKD) and a Corporate VP and CFO in MANNKIND CORP ($MNKD) and a Director in MANNKIND CORP ($MNKD).
Address: C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which MATTHEW J PFEFFER is an Insider
CELL GENESYS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW J PFEFFER: V.P. & Chief Financial Officer
Holdings: 22,503 shares
Latest Transaction: Aug 04 2003
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MANNKIND CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW J PFEFFER: CEO, CFO, Director, Corporate VP and CFO
Holdings: 81,961 shares
Current Value: $41,800
Latest Transaction: Aug 29 2017
$MNKD Market Capitalization: $244.02M
$MNKD Previous Close: $0.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SECOND SIGHT MEDICAL PRODUCTS INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of MATTHEW J PFEFFER: Director
Holdings: 118,301 shares
Current Value: $183,367
Latest Transaction: Jun 05 2019
$EYES Market Capitalization: $116.60M
$EYES Previous Close: $1.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MATTHEW J PFEFFER
Sentiment: All, CEGE, MNKD, EYES
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 05 2019 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 0.71 | 56,685 | 40,178 | 56,685 | |
| Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
| Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Grant | A | 0.00 | 35,533 | 0 | 118,301 | 82.8 K to 118.3 K (+42.93 %) |
| Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
| Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Grant | A | 0.00 | 35,533 | 0 | 118,301 | 82.8 K to 118.3 K (+42.93 %) |
| Aug 29 2017 | MNKD | MANNKIND CORP | PFEFFER MATTHEW J | Director | Payment of Exercise | F | 1.55 | 303 | 470 | 81,961 | 82.3 K to 82 K (-0.37 %) |
| Aug 23 2017 | MNKD | MANNKIND CORP | PFEFFER MATTHEW J | Director | Payment of Exercise | F | 1.41 | 170 | 240 | 82,264 | 82.4 K to 82.3 K (-0.21 %) |